PMA supplement
P140012 S013: ReShape Integrated Dual Balloon System
FDA PMA supplement · Special (Immediate Track) · Boston Scientific Corporation
Key facts
| Original PMA | P140012 |
|---|---|
| Supplement number | S013 |
| Supplement type | Special (Immediate Track) |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | ReShape Integrated Dual Balloon System |
| Generic name | IMPLANT, INTRAGASTRIC FOR MORBID OBESITY |
| Applicant | Boston Scientific Corporation |
| Product code | LTI |
| Received date | May 2, 2018 |
| Decision date | May 31, 2018 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: